SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19

URN to cite this document:: urn:nbn:de:bvb:355-epub-526932
DOI to cite this document:: 10.5283/epub.52693

Glück, Vivian ; Grobecker, Sonja ; Tydykov, Leonid ; Salzberger, Bernd

; Glück, Thomas ; Weidlich, Tanja ; Bertok, Manuela ; Gottwald, Christine ; Wenzel, Jürgen J.

; Gessner, André

; Schmidt, Barbara

; Peterhoff, David

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 01 Aug 2022 08:25

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Objective To follow serological immune responses of front-line healthcare workers after PCR-confirmed COVID-19 for a mean of 30 weeks, describe the time-course of SARS-CoV-2 spike protein-specific IgG, IgA and IgM levels and to identify associations of the immune response with symptoms, demographic parameters and severity of disease. Methods Anti-SARS-CoV-2 S protein-specific IgG, IgA and IgM ...